[NBIX] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
05-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 703.99%
YoY- 923.24%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 296,000 288,900 236,600 247,900 258,500 302,400 237,100 15.92%
PBT 30,500 57,500 27,200 41,700 -57,100 83,200 38,900 -14.95%
Tax 8,000 15,200 -4,900 -306,200 500 3,600 1,500 204.94%
NP 22,500 42,300 32,100 347,900 -57,600 79,600 37,400 -28.71%
Tax Rate -26.23% -26.43% 18.01% 734.29% - -4.33% -3.86% -
Total Cost 273,500 246,600 204,500 -100,000 316,100 222,800 199,700 23.30%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 7.60 14.64 13.57 140.34 -22.28 26.32 15.77 -38.50%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS 0.24 0.45 0.34 3.72 -0.62 0.86 0.40 -28.84%
EPS Diluted 0.23 0.43 0.33 3.58 -0.62 0.81 0.39 -29.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.